Table 9 Top ten paths of Xanthium compounds—three diabetes terms.
From: An automatic hypothesis generation for plausible linkage between xanthium and diabetes
Rank | Path | Score |
|---|---|---|
Type 1 diabetes | ||
1 | beta_sitosterol—[Stimulates]—glucose—[Associated with]—type_1_diabetes | 0.822 |
2 | rhamnose—[Associated with]—glucose—[Associated with]—type_1_diabetes | 0.820 |
3 | adenosine—[Associated with]—labetalol—[Associated with]—glucose—[Associated with]—type_1_diabetes | 0.819 |
4 | alkaloids—[Parts of]—aucubin—[Treats]—glucose—[Associated with]—type_1_diabetes | 0.819 |
5 | adenosine—[Coexists with]—allicin—[Affects]—glucose—[Associated with]—type_1_diabetes | 0.818 |
6 | scopoletin—[Stimulates]—glucose—[Associated with]—type_1_diabetes | 0.818 |
7 | alkaloids—[Associated with]—phenytoin—[Causes]—glucose—[Associated with]—type_1_diabetes | 0.818 |
8 | beta_sitosterol—[Stimulates]—glucose—[Associated with]—methanol—[Neg Affects]—type_1_diabetes | 0.818 |
9 | oleic_acid—[Neg Affects]—gallic_acid—[Stimulates]—glucose—[Associated with]—type_1_diabetes | 0.817 |
10 | rhamnose—[Associated with]—glucose—[Associated with]—methanol—[Associated with]—type_1_diabetes | 0.817 |
Type 2 diabetes | ||
1 | alkaloids—[Administered to]—diabetic_complication—[Associated with]—autoimmune_disease—[Associated with]—type_2_diabetes | 0.824 |
2 | alkaloids—[Administered to]—diabetic_complication—[Causes]—arthritis—[Associated with]—type_2_diabetes | 0.823 |
3 | alkaloids—[Administered to]—diabetic_complication—[Associated with]—autoimmune_disease—[Associated with]—type_2_diabetes | 0.822 |
4 | alkaloids—[Administered to]—diabetic_complication—[Causes]—vasculitis—[Associated with]—type_2_diabetes | 0.822 |
5 | quercetin—[Coexists with]—diabetic_complication—[Associated with]—autoimmune_disease—[Associated with]—type_2_diabetes | 0.821 |
6 | alkaloids—[Administered to]—diabetic_complication—[Causes]—neurological_disorder—[Associated with]—type_2_diabetes | 0.821 |
7 | alkaloids—[Administered to]—diabetic_complication—[Associated with]—chronic_lung_disease—[Associated with]—type_2_diabetes | 0.820 |
8 | alkaloids—[Administered to]—diabetic_complication—[Causes]—optic_neuropathy—[Associated with]—type_2_diabetes | 0.820 |
9 | quercetin—[Coexists with]—diabetic_complication—[Causes]—arthritis—[Associated with]—type_2_diabetes | 0.820 |
10 | alkaloids—[Administered to]—diabetic_complication—[Associated with]—hypokalemia—[Associated with]—type_2_diabetes | 0.820 |
Diabetes Mellitus | ||
1 | adenosine—[Treats]—congestive_heart_failure—[Associated with]—diabetes_mellitus | 0.853 |
2 | adenosine—[Treats]—asthma—[Associated with]—diabetes_mellitus | 0.852 |
3 | adenosine—[Neg Affects]—luteolin—[Stimulates]—diabetes_mellitus | 0.850 |
4 | alkaloids—[Causes]—hyperlipidemia—[Associated with]—diabetes_mellitus | 0.850 |
5 | adenosine—[Treats]—lymphoma—[Associated with]—diabetes_mellitus | 0.850 |
6 | adenosine—[Associated with]—inflammatory_bowel_disease—[Associated with]—diabetes_mellitus | 0.849 |
7 | alkaloids—[Treats]—heart_disease—[Associated with]—diabetes_mellitus | 0.849 |
8 | alkaloids—[Associated with]—autoimmune_disease—[Associated with]—diabetes_mellitus | 0.848 |
9 | adenosine—[Treats]—pulmonary_disease—[Associated with]—diabetes_mellitus | 0.847 |
10 | alkaloids—[Treats]—metabolic_disease—[Associated with]—diabetes_mellitus | 0.847 |
